{Reference Type}: Case Reports
{Title}: Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex.
{Author}: Le Cras R;Mazet R;Dubois-Teklali F;Sabourdy C;Chanoine S;Lehmann A;Morin A;Leenhardt J;Durand M;Desruet MD;Bedouch P;
{Journal}: Emerg Microbes Infect
{Volume}: 12
{Issue}: 1
{Year}: Dec 2023
{Factor}: 19.568
{DOI}: 10.1080/22221751.2022.2148563
{Abstract}: Subacute sclerosing panencephalitis (SSPE) is a late-onset and fatal viral disease caused by persistent infection of the central nervous system by measles virus (MeV). We present the case of a 10-year-old child from South Asia affected by SSPE, stabilized with a combination of intrathecal interferon-α2b (INF-α2b) injections and oral inosiplex and how we continued the treatment when inosiplex was commercially stopped worldwide.